163 related articles for article (PubMed ID: 28161933)
1. Education Level Is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: A Study Based on the Nationwide Korean Breast Cancer Registry Database.
Hwang KT; Noh W; Cho SH; Yu J; Park MH; Jeong J; Lee HJ; Kim J; Oh S; Kim YA;
Cancer Res Treat; 2017 Oct; 49(4):1114-1126. PubMed ID: 28161933
[TBL] [Abstract][Full Text] [Related]
2. Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.
Hwang KT; Kim J; Kim EK; Jung SH; Sohn G; Kim SI; Jeong J; Lee HJ; Park JH; Oh S;
Clin Breast Cancer; 2017 Jul; 17(4):e169-e184. PubMed ID: 28169145
[TBL] [Abstract][Full Text] [Related]
3. Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society.
Park S; Moon BI; Oh SJ; Lee HB; Seong MK; Lee S; Byun KD; Jung SP; Bae SY
Breast Cancer Res Treat; 2019 Feb; 173(3):679-691. PubMed ID: 30390214
[TBL] [Abstract][Full Text] [Related]
4. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
[TBL] [Abstract][Full Text] [Related]
5. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
6. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
7. Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
Yoon TI; Hwang UK; Kim ET; Lee S; Sohn G; Ko BS; Lee JW; Son BH; Kim S; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2017 Sep; 165(2):311-320. PubMed ID: 28601930
[TBL] [Abstract][Full Text] [Related]
8. Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.
Lee JS; Kim HA; Cho SH; Lee HB; Park MH; Jeong J; Park HK; Oh M; Yi O
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1717-1726. PubMed ID: 31244292
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.
Lim ST; Choi JE; Kim SJ; Kim HA; Kim JY; Park HK; Suh YJ
Breast Cancer Res Treat; 2016 Apr; 156(3):473-483. PubMed ID: 27041335
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
Braunstein LZ; Taghian AG; Niemierko A; Salama L; Capuco A; Bellon JR; Wong JS; Punglia RS; MacDonald SM; Harris JR
Breast Cancer Res Treat; 2017 Jan; 161(1):173-179. PubMed ID: 27807809
[TBL] [Abstract][Full Text] [Related]
12. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
13. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
14. A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society.
Kim HJ; Kim HJ; Lee SB; Moon HG; Noh WC; Cho YU; Yoo Y; Ahn SH;
Breast Cancer Res Treat; 2015 Aug; 153(1):153-60. PubMed ID: 26223812
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in young women with breast cancer: a population-based study.
Fredholm H; Magnusson K; Lindström LS; Garmo H; Fält SE; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
Breast Cancer Res Treat; 2016 Nov; 160(1):131-143. PubMed ID: 27624330
[TBL] [Abstract][Full Text] [Related]
16. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
18. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.
Ryu JM; Lee HJ; Yoon TI; Lee ES; Lee SJ; Jung JH; Chae BJ; Nam SJ; Lee JE; Lee SK; Bae SY; Yu J; Kim SW;
Breast Cancer Res Treat; 2016 Oct; 159(3):489-98. PubMed ID: 27590199
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
